- Therapeutic use
- Alkylating agent, Antineoplastic
| Availability | API , FDF |
| Molecular Formula | C6H6N6O |
| IUPAC Nomenclature | 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-as-tetrazine-8-carboxamide |
| Therapeutic Category | Antineoplastic, alkaylating agent |
| CAS Number | 85622-93-1 |
| Presentation | 5/20/100/250 mg capsules |
